Damora Therapeutics (DMRA) Tax Provisions (2024 - 2026)
Damora Therapeutics (DMRA) posted Tax Provisions of $42000.0 for Q1 2026, down 4.55% on a QoQ basis from $44000.0 in Q4 2025, and up 2000.0% year-over-year from $2000.0 in Q1 2025.
Damora Therapeutics (DMRA) Tax Provisions (2024 - 2026) Analysis & Trends
Damora Therapeutics' Tax Provisions history runs 3 years deep, the most recent figure standing at $42000.0 for Q1 2026.
- Quarterly Tax Provisions rose 2000.0% year-over-year to $42000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $90000.0 (up 109.3% YoY) and the FY2025 annual result came in at $50000.0, up 21.95% from the prior year.
- Tax Provisions was $42000.0 for Q1 2026 at Damora Therapeutics, down from $44000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $44000.0 in Q4 2025 and bottomed at -$8000.0 in Q4 2024.
- A 3-year average of $19000.0 and a median of $7000.0 in 2024 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2025 — Tax Provisions plunged 90.48% — and 2026, when it surged 2000.0%.
- Damora Therapeutics' Tax Provisions stood at -$8000.0 in 2024, then soared by 650.0% to $44000.0 in 2025, then dropped by 4.55% to $42000.0 in 2026.
- Business Quant data shows DMRA's Tax Provisions at $42000.0 in Q1 2026, $44000.0 in Q4 2025, and $4000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Damora Therapeutics | 986.02 Mn | 783.62 Mn | - | 42,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | -8,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 42,000.00 |